NAD+
Overview
Research-use coenzyme supplied for studies of redox biology, cellular energy metabolism, and NAD-dependent enzyme pathway models.
- Concentration
- 500 mg
- Stock
- In stock
Product details
NAD+ is a cellular coenzyme used in research models of redox biology, energy metabolism, and NAD-dependent enzyme pathways. Pattern lists this material for controlled laboratory research.
Research Targets: Sirtuins, PARPs, CD38, mitochondrial redox systems, NAD-dependent enzyme networks.
Key Feature: Central redox and metabolic cofactor for pathway research.
Research Focus Areas: Mitochondrial function models, aging biology, DNA repair pathway studies, cellular stress-response research.
Common Models: Cellular metabolism assays, oxidative-stress models, aging and DNA-repair pathway studies.
Mechanistic Interests: Redox cycling, sirtuin pathway markers, PARP-associated signaling, metabolic resilience models.
Use Boundary: Research use only; not for human or veterinary use; no diagnostic, therapeutic, or consumption use is implied.
Research context
Peptide guide
Open full guide- Guide profile
- Nicotinamide Adenine Dinucleotide
- Composition
- Vital coenzyme present in every cell, functioning as a key mediator in energy metabolism, mitochondrial function, DNA repair, sirtuin activation, and redox reactions
- Discovery
- First identified in 1906 during yeast fermentation studies by Arthur Harden and William Young
- Research scope
- Evidence stems from preclinical models (animals, cells) showing NAD+ restoration improves mitochondrial function, insulin sensitivity, neuroprotection, and lifespan extension
- Regulatory status
- Not FDA-approved for any indication; precursors have stronger data
Safety context
- Not approved by major regulatory bodies (e.g., FDA) for therapeutic use
- Experts often prefer precursors for bioavailability and evidence
- Limited strong human trial support for most claims
Research-use notice: It is not approved by major regulatory bodies for therapeutic use, and long-term safety (e.g., cancer risk unknowns) remains understudied. Always consult a qualified healthcare professional before considering NAD+ for personal application.
Full guide includes 10 reference entries.
This product does not have enough stock for a 10-vial kit.